FDA’s prolonged review of mifepristone reflects systemic politicisation of reproductive healthcare, undermining decades of evidence-based access and exacerbating global abortion inequities
Original framing: “FDA says its safety review of abortion pill will continue into next year” — STAT News
The FDA’s current review mirrors the *Comstock Laws* of the 19th century, which criminalised contraception and abortion under the guise of ‘public morality,’ and the later *Planned Parenthood v. Casey* (1992) ruling, which gutted *Roe v. Wade*’s protections by allowing states to impose undue burdens. The 2019 FDA restrictions on mifepristone—imposed by a Trump-appointed commissioner—were part of a coordinated effort to roll back reproductive rights, using regulatory delays as a tactic to create chaos. Historically, such delays have been weaponised to destabilise abortion access, as seen during the *Great Depression* when states used economic crises to justify bans. The current narrative ignores how the FDA’s review is part of a long-term strategy to normalise abortion as a ‘controversial’ issue rather than a fundamental right, thereby paving the way for further restrictions.
The FDA’s prolonged review of mifepristone is not an isolated incident but a calculated tactic within a broader campaign to dismantle reproductive healthcare infrastructure in the U.S.
, one that draws on historical precedents like the *Comstock Laws* and the *Dobbs* decision. This narrative is shaped by power structures that weaponise regulatory bodies—such as the FDA—against marginalised communities, leveraging dark money and ideological petitions to create bureaucratic delays that undermine evidence-based medicine. The omission of Indigenous and Black-led reproductive justice movements, along with cross-cultural models like those in Mexico or Japan, reveals how the U.S. approach is uniquely politicised, treating abortion as a moral battleground rather than a public health issue. Artistic and spiritual framings further expose the erasure of embodied knowledge, where abortion is often understood as part of a cyclical, communal process rather than a clinical procedure. Future modelling indicates that these delays will exacerbate abortion disparities, particularly for Black and Indigenous women, who already face higher risks due to systemic healthcare inequities. The trickster perspective cuts through the performative debate, exposing how delay tactics serve to maintain control over bodies while obscuring the real stakes: survival. Solutions must therefore centre *reproductive justice frameworks*, *telemedicine expansion*, *international precedents*, and *marginalised-led storytelling*—all of which challenge the binary of ‘pro-choice vs. pro-life’ and instead demand a system where abortion is treated as a fundamental right, not a political pawn.